These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6146387)

  • 1. Evidence for vasoactive intestinal polypeptide as a neurotransmitter in smooth muscle of the urogenital tract.
    Hunter JC; Maggio JE; Mantyh PW
    Brain Res; 1984 Jul; 305(2):221-9. PubMed ID: 6146387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of vasoactive intestinal polypeptide and of adenosine 5'-triphosphate on the isolated anococcygeus muscle of the mouse.
    Gibson A; Tucker JF
    Br J Pharmacol; 1982 Sep; 77(1):97-103. PubMed ID: 7127000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection.
    Willis EA; Ottesen B; Wagner G; Sundler F; Fahrenkrug J
    Life Sci; 1983 Jul; 33(4):383-91. PubMed ID: 6410140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscle.
    Blank MA; Brown JR; Hunter JC; Bloom SR; Tyers MB
    Eur J Pharmacol; 1986 Dec; 132(2-3):155-61. PubMed ID: 3816973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.
    Ny L; Larsson B; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Andersson KE
    Br J Pharmacol; 1995 Dec; 116(7):2873-80. PubMed ID: 8680719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vasoactive intestinal polypeptide (VIP) on rabbit cavernosal smooth muscle contractility.
    Kim YC; Choi HK; Ahn YS; Kim KH; Hagen PO; Carson CC
    J Androl; 1994; 15(5):392-7. PubMed ID: 7860419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide: a neurotransmitter for relaxation of the rabbit internal anal sphincter.
    Biancani P; Walsh J; Behar J
    Gastroenterology; 1985 Oct; 89(4):867-74. PubMed ID: 2863193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
    Larsen JJ; Ottesen B; Fahrenkrug J; Fahrenkrug L
    Invest Urol; 1981 Nov; 19(3):211-3. PubMed ID: 7298295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies on VIP as non-cholinergic and non-adrenergic neurotransmitter in bladder neck and posterior urethra].
    Hosokawa H; Kaseda M
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):440-9. PubMed ID: 8099983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against vasoactive intestinal polypeptide as the relaxant neurotransmitter in human cavernosal smooth muscle.
    Pickard RS; Powell PH; Zar MA
    Br J Pharmacol; 1993 Feb; 108(2):497-500. PubMed ID: 8095418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus.
    Lefebvre RA; Smits GJ; Timmermans JP
    Br J Pharmacol; 1995 Oct; 116(3):2017-26. PubMed ID: 8640340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innervation of the anococcygeus muscle of the rat.
    Dail WG; Carrillo Y; Walton G
    Cell Tissue Res; 1990 Jan; 259(1):139-46. PubMed ID: 2297780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of non-adrenergic non-cholinergic inhibitory and excitatory neurotransmitters in a large neuronal subpopulation in the vaginal segment of the chicken oviduct.
    Costagliola A; De Man JG; Majewski M; Lakomy M; Cecio A; Robberecht P; Pelckmans PA; Adriaensen D; Timmermans JP
    Auton Neurosci; 2004 May; 112(1-2):37-48. PubMed ID: 15233929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
    Fung C; Unterweger P; Parry LJ; Bornstein JC; Foong JP
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G748-58. PubMed ID: 24578344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S; Rattan S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative distribution of vasoactive intestinal polypeptide (VIP), substance P and PHI in the enteric sphincters of the cat.
    McGregor GP; Bishop AE; Blank MA; Christofides ND; Yiangou Y; Polak JM; Bloom SR
    Experientia; 1984 May; 40(5):469-71. PubMed ID: 6202546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical localization and some pharmacological effects of vasoactive intestinal polypeptide in human and monkey corpus cavernosum.
    Steers WD; McConnell J; Benson GS
    J Urol; 1984 Nov; 132(5):1048-53. PubMed ID: 6436509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation.
    Duckles SP; Said SI
    Eur J Pharmacol; 1982 Mar; 78(3):371-4. PubMed ID: 6121712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract.
    Ottesen B
    Am J Obstet Gynecol; 1983 Sep; 147(2):208-24. PubMed ID: 6137145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.